- Home
- NEXN vs BNTC Comparison
NEXN vs BNTC Comparison
Compare NEXN & BNTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NEXN | BNTC |
|---|---|---|
| Founded | 2007 | 1995 |
| Country | Israel | United States |
| Employees | 909 | N/A |
| Industry | Computer Software: Programming Data Processing | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 381.1M | 411.4M |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | NEXN | BNTC |
|---|---|---|
| Price | $7.03 | $13.06 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 3 |
| Target Price | $11.56 | ★ $27.67 |
| AVG Volume (30 Days) | ★ 252.5K | 96.8K |
| Earning Date | 05-13-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 80.94 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $9.64 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $5.60 | $9.85 |
| 52 Week High | $12.00 | $17.15 |
Technical Indicators
Market Signals| Indicator | NEXN | BNTC |
|---|---|---|
| Relative Strength Index (RSI) | 59.64 | 71.97 |
| Support Level | $6.23 | $12.79 |
| Resistance Level | $7.71 | $14.13 |
| Average True Range (ATR) | 0.31 | 0.65 |
| MACD | 0.03 | 0.24 |
| Stochastic Oscillator | 81.86 | 99.86 |
Price Performance
Historical ComparisonAbout NEXN Nexxen International Ltd. American Depository Shares
Nexxen International Ltd is a globalized and flexible advertising technology platform with deep expertise in data and TV that helps empower advertisers, agencies, digital publishers, broadcasters, and others. The Digital Advertising Ecosystem of the company includes demand-side platform (DSP), supply-side platform (SSP), ad server, and data management platform (DMP) and also delivers a flexible and unified technology stack with and exclusive data at its core. The company operates in America, APAC, EMEA, and Rest of America, with majority revenue from America.
About BNTC Benitec Biopharma Inc.
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.